McCarthy Daniel Joseph

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
McCarthy Daniel Joseph's trades of Evolent Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
296.88
Quantity 49,363 +27.6%
Value US$2,791,065
Transaction date
Proposed sale
Price
362.24
Quantity 34,591
Value US$1,402,524
Transaction date
Purchase
Price
241.94
Quantity 68,519 -19.2%
Value US$2,781,586
Transaction date
Planned sale
Price
33.00
Quantity 4,000 -2.1%
Value US$132,000
Transaction date
Planned sale
Price
32.00
Quantity 6,469 -3.3%
Value US$207,008
Transaction date
Planned sale
Price
33.00
Quantity 7,000 -3.4%
Value US$231,000
Transaction date
Planned sale
Price
30.00
Quantity 16,693 -7.5%
Value US$500,790
Transaction date
Proposed sale
Price
32.63
Quantity 34,162
Value US$1,114,706
US Insmed Inc (INSM)
Transaction date
Proposed sale
Price
32.63
Quantity 34,162
Value US$1,114,706
Transaction date
Planned sale
Price
30.00
Quantity 3,000 -1.5%
Value US$90,000
Transaction date
Planned sale
Price
30.00
Quantity 4,000 -2.0%
Value US$120,000
Transaction date
Planned sale
Price
30.00
Quantity 4,000 -1.9%
Value US$120,000
Transaction date
Proposed sale
Price
29.95
Quantity 11,000
Value US$329,447
Transaction date
Planned sale
Price
31.44
Quantity 1,000 -0.5%
Value US$31,440
Transaction date
Proposed sale
Price
31.39
Quantity 1,000
Value US$31,390
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-28 2026-08-26
PlS Planned sale
49,363 +27.6%
296.88
US$2,791,065 		49,363 +27.6% 296.88 US$2,791,065
2026-08-26 2026-08-26
PrS Proposed sale
34,591
362.24
US$1,402,524 		34,591 362.24 US$1,402,524
2025-03-10 2025-03-06
B Purchase
68,519 -19.2%
241.94
US$2,781,586 		68,519 -19.2% 241.94 US$2,781,586
2024-08-26 2024-08-23
PlS Planned sale
4,000 -2.1%
33.00
US$132,000 		4,000 -2.1% 33.00 US$132,000
2024-08-26 2024-08-23
PlS Planned sale
6,469 -3.3%
32.00
US$207,008 		6,469 -3.3% 32.00 US$207,008
2024-08-26 2024-08-22
PlS Planned sale
7,000 -3.4%
33.00
US$231,000 		7,000 -3.4% 33.00 US$231,000
2024-08-26 2024-08-22
PlS Planned sale
16,693 -7.5%
30.00
US$500,790 		16,693 -7.5% 30.00 US$500,790
2024-08-23 2024-08-22
PrS Proposed sale
34,162
32.63
US$1,114,706 		34,162 32.63 US$1,114,706
2024-08-22 2024-08-22
US Insmed Inc (INSM)
PrS Proposed sale
34,162
32.63
US$1,114,706 		34,162 32.63 US$1,114,706
2023-11-20 2023-11-15
PlS Planned sale
3,000 -1.5%
30.00
US$90,000 		3,000 -1.5% 30.00 US$90,000
2023-11-20 2023-11-15
PlS Planned sale
4,000 -2.0%
30.00
US$120,000 		4,000 -2.0% 30.00 US$120,000
2023-11-20 2023-11-15
PlS Planned sale
4,000 -1.9%
30.00
US$120,000 		4,000 -1.9% 30.00 US$120,000
2023-11-15 2023-11-15
PrS Proposed sale
11,000
29.95
US$329,447 		11,000 29.95 US$329,447
2023-06-14 2023-06-12
PlS Planned sale
1,000 -0.5%
31.44
US$31,440 		1,000 -0.5% 31.44 US$31,440
2023-06-12 2023-06-12
PrS Proposed sale
1,000
31.39
US$31,390 		1,000 31.39 US$31,390